Posted on

Impro: Share price of U.S. peer up nearly 300% in three years. Impro issues positive profit alert with extremely low comparable valuation

HONG KONG, Jan 16, 2023 - (ACN Newswire via SEAPRWire.com) - The latest macro data published by the U.S. is not ideal. The market expects the Fed will continue to raise interest rates through to the end of 2023. By then, the federal funds rate may reach 4.9% and the higher interest rate level will once again trigger market concerns about asset price revaluation. It is clear that US stocks have been under pressure recently. U.S. peer Howmet's share price has risen by over 300% in the last three yearsFor well-managed companies, there is never a shortage of capital and opportunity in the capital market. The stock price of Howmet Aerospace (US stock code: HWM) has been on an upward trajectory, hitting new all-time highs. It has increased from a low of US$9.87 in May 2020 to a closing price of US$40.55 on 10 January this year, representing a surge of close to 300% in three years and nearly 30% in the last six months. Howmet is a global leader in engineered metal castings and precision machining products. It is the second largest in the industry in terms of investment casting sales (the market leader is Precision Castparts Corp., which Warren Buffett took private in 2015) with a current market capitalization of US$16.8 billion. Its price-to-earning (P/E) ratio is estimated at 38.6 times, and its price-to-book (P/B) ratio and price-to-sales (P/S) ratio is 5.1 times and 3.0 times, respectively.Impro's valuation is extremely low compared with HowmetImpro (01286.HK) is a company listed on the Hong Kong capital market and is engaged in the same investment casting business as Howmet. It is a world-leading manufacturer of high-precision, high-complexity and mission-critical casting and machined components, and the sixth largest investment casting manufacturer in the world and the largest in China. Compared with Howmet, Impro's current market capitalization is only US$620 million (HK$4.9 billion), with a P/E ratio of approximately 8 times, a P/B ratio of 1.1 times and a P/S ratio of 0.9 time. It is evident that the Company is significantly undervalued.Impro Precision issues positive profit alert Results is set for further growth As one of the world's top ten manufacturers of high-precision castings and machined components, Impro Precision is underestimated and has huge scope for further growth. The Company recently issued a positive profit alert. Its sales revenue for 2022 is expected to increase by 15% to HK$4.35 billion, with net profit of HK$550-600 million, a year-on-year increase of 43-56%. Like Howmet, Impro Precision has also benefited from the recovery of its aerospace business after the pandemic. With the market for aircraft parts in short supply, the Company's future performance has great potential. Despite the Company's record net profit and sales revenue, its share price closed at only HK$2.65, still below its all-time high and in the bottom range. Compared with the historical high of HK$5.20, there is still considerable room for upward movement.Leading stock in high-precision parts industry in Hong Kong Aerospace and Hydraulics businesses will become its new growth engineAs one of the few leading high-precision component companies in the Hong Kong stock market, with strong economies of scale, the Company's sales exceeded HK$4.3 billion in 2022, and it has established a global presence. To date, the Company has 21 plants, 10 sales offices and eight logistics and warehousing centers in North America, Europe and Asia. It also completed the acquisition of Foshan Ameriforge at a consideration of nearly RMB59 million and the hydraulic orbital motor business of Danfoss Power Solutions (Jiangsu) Co., Ltd., a subsidiary of Danfoss Group, for EUR65 million, on 15 August and 31 October 2022, respectively, to strengthen the Company's presence in the aerospace and hydraulics industries.One of the revaluation targets under a valuation system with Chinese characteristicsOn 21 November 2022, at the Annual Conference of Financial Street Forum 2022, Yi Huiman, Chairman of the China Securities Regulatory Commission, speaking on the structure and valuation of listed companies, said that there was a need to explore ways to build a valuation system with Chinese characteristics, so as to promote better functioning of the market's resource allocation.Obviously, the regulator has clearly recognized that it is very unreasonable for a number of listed companies, including Hong Kong stocks and A-shares, to be extremely undervalued by the market. The regulator has pointed out that it is necessary to conduct an in-depth study on the application scenarios of valuation theories in mature markets and grasp the valuation logic of different types of listed companies. It is believed that the signal from the regulator to explore the establishment of a valuation system with Chinese characteristics will be gradually developed and implemented at the level of investment banks and institutional investors. Compared with overseas benchmarking companies, the valuation of Impro is extremely unreasonable. The history of the development of the US stock market shows that a reasonable revaluation of the value of a listed company may be late, but it is never missed.Moreover, the market capitalization of Impro will soon exceed HK$5 billion, and it is likely to be included in the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect in the second half of this year, giving mainland investors the opportunity to invest in Impro. As a rare leader in the high-precision components industry, the Company has maintained continuous growth in its business performance. It is believed that, under the catalyst of multiple factors, Impro will move further along the new capital market curve. Copyright 2023 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024

NEW YORK, NY, Jan 16, 2023 - (JCN Newswire via SEAPRWire.com) - PCG Digital -- Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company, is on track to deliver a safe and effective front-line treatment to a community of patients living with a rare, chronic cancer.[Image: Soligenix, Inc.]Cutaneous T-cell lymphoma (CTCL) is difficult to treat and remains an area of significant unmet medical need, with a very limited number of safe treatment options available. Soligenix estimates the potential worldwide market for its therapeutic, HyBryte(TM)(synthetic hypericin), to be in excess of $250 million for the treatment of CTCL.Soligenix accomplished a number of key milestones in 2022, but difficult global market conditions meant the company was unable to achieve the stock price gains it had hoped for.Soligenix has announced its intention to seek shareholder approval for a reverse stock split next month.Watch the video interview with Soligenix President and Chief Executive Officer, Dr. Christopher Schaber on Jan 12 to hear more: https://youtu.be/YLh2M_8DsUE.Q: Why did you decide a reverse stock split was the best course of action for Soligenix, and why now?A: The primary goal of a reverse stock split will be to maintain Soligenix's Nasdaq listing. As we wait for a potential NDA approval from the FDA, and work towards the US launch of HyBryte, it is a critical time to remain a Nasdaq listed company.A reverse stock split may also serve to increase the trading price of our common stock, making Soligenix a more attractive value proposition to a broader range of investors, including institutional investors. It also has the potential to support any future capital-raising efforts.We were in discussions with Nasdaq during 2022 to request additional time to regain compliance and did not take pursuit of this action lightly. We waited as long as we could to ensure we had time to announce all of our key milestones during the year, most notably the submission of our new drug application (NDA) for HyBryte(TM) in the treatment of CTCL, which has a global market potential of approximately $250 million.Q: How will remaining on the Nasdaq create opportunities for Soligenix shareholders?A: We see significant potential upside for Soligenix's shareholders. Increasing our trading price will, we believe, encourage new investor interest in Soligenix, potentially resulting in greater liquidity for our shareholders. Institutions are often reluctant to buy stocks with a price below a certain threshold, and a higher share price would increase Soligenix's marketability, trading volume and liquidity of our common stock. Similarly, we may see renewed interest from analysts and brokers that typically avoid following or recommending companies with low stock prices.Our Board of Directors has thoroughly reviewed Soligenix's position and options and has approved the reverse stock split as being in the company's best interests.Q: Soligenix has indicated it is expecting to achieve some significant milestones in 2023. Can you expand on that?A: Soligenix is expecting to achieve a number of important milestones in 2023. We are anticipating the FDA's acceptance of our NDA for review in the first half of the year, and later in the year, the potential NDA approval in the US of HyBryte.In Q4 2022, Soligenix was invited by the Biomedical Advanced Research and Development Authority (BARDA) to submit a full contract proposal for the development of single-vial, adjuvanted, heat stable subunit vaccines to prevent filovirus infection. We are expecting to hear from BARDA about this potential multi-year, multi-million dollar contract award for our vaccine candidates, SuVax(TM) and MarVax(TM), against Ebola and Marburg viruses.Also, in Q4 2022, Soligenix initiated a Phase 2 clinical trial of SGX302 (synthetic hypericin) for the treatment of mild-to-moderate psoriasis. We are excited to expand synthetic hypericin's development into different cutaneous T-cell diseases such as psoriasis, as we execute on our long-term strategy to enhance the value of this unique compound. Psoriasis is a widespread unmet medical need, affecting as many as 7.5 million people in the U.S. and between 60 and 125 million people worldwide. We expect to report results from the study in the second half of 2023.Q: Following FDA approval, what will be next for HyBryte?A: Our NDA for HyBryte has been granted FDA orphan drug and fast track designations, due to its potential as a safe and effective front-line treatment for CTCL. We are anticipating potential approval in the second half of 2023 and we are targeting the first quarter of 2024 for our US launch.Additionally, we announced in September 2022 that the FDA had awarded a $2.6 million Orphan Products Development grant for an expanded study of HyBryte(TM) in the treatment of CTCL, including in the home use setting. The home use setting is a very important growth area for us, so we are very excited that this investigator-initiated study will begin in the first half of this year.Our goal remains to deliver an innovative first-in-class therapy to the CTCL community, and we believe we are on track to achieve this important goal.For further information regarding Soligenix, Inc., please visit the Company's website at www.soligenix.com, subscribe to the YouTube channel @Soligenix, and follow on LinkedIn and Twitter at Soligenix_Inc.- YouTube: https://www.youtube.com/@SoligenixInc- LinkedIn: https://www.linkedin.com/company/soligenix-inc-/- Twitter: https://twitter.com/Soligenix_IncPCG DigitalE: info@pcgadvisory.comT: +1-646-863-6341DisclaimerThis communication was produced by PCG Digital Holdings, LLC, an affiliate of PCG Advisory Inc., (together "PCG"). PCG is not a registered or licensed broker-dealer nor investment adviser. No information contained in this communication constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security. PCG may be compensated by respective clients for publicizing information relating to its client's securities. See www.pcgadvisory.com/disclosures. Copyright 2023 JCN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Champion REIT Partners with St. James’ Settlement in Summer Movie Screening for SEN Children

HONG KONG, Aug 22, 2022 - (ACN Newswire via SEAPRWire.com) - Champion Real Estate Investment Trust ("Champion REIT" or the "Trust") (Stock Code: 2778), owner of Three Garden Road and Langham Place, partnered with St. James' Settlement again this year to hold a movie screening of Doraemon: Nobita's Little Star Wars at Cinema City, Langham Place Mall. The event targeted underprivileged families living in Tin Shui Wai and their children with special educational needs (SEN), including autism, attention deficit hyperactivity disorder (ADHD), etc. Volunteers from Champion REIT enjoy watching the movie Doraemon: Nobita's Little Star Wars with the family beneficiariesVolunteers from Champion REIT promote diversity and inclusion in the communityFollowing the success of last year's Women Empowerment Programme - Champion Mothers, the event not only marked the Trust's continued collaboration with St. James' Settlement, but also provided a volunteering opportunity for staff members and their families to present gifts to the children, promoting social diversity and inclusion whilst sharing an enjoyable summer experience.The Trust has never forgotten its philosophy of giving back to society. It remains committed to working with non-profit organisations to create shared values and provide assistance to those in need in the community.About Champion REIT (Stock Code: 2778)Champion Real Estate Investment Trust is a trust formed to own and invest in income producing office and retail properties. The Trust focuses on Grade A commercial properties in prime locations. It currently offers investors direct exposure to nearly 3 million sq. ft. of prime office and retail floor area. These include two Hong Kong landmark properties, Three Garden Road and Langham Place, as well as joint venture stake in 66 Shoe Lane in Central London. Since 2015, the Trust has been included in the Constituent of Hang Seng Corporate Sustainability Benchmark Index of Hang Seng Indexes.Website: www.championreit.com For press inquiries:Strategic Financial Relations LimitedVicky Lee Tel: 2864 4834 Email: vicky.lee@sprg.com.hkChristina Cheuk Tel: 2114 4979 Email: christina.cheuk@sprg.com.hkYvonne Lee Tel: 2864 4847 Email: yvonne.lee@sprg.com.hk Website: www.sprg.com.hk Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

China-Euro Stock Connect Launch to a Flying Start, Gotion High-Tech GDR is officially listed on the SIX Swiss Exchange

HONG KONG, Aug 1, 2022 - (ACN Newswire via SEAPRWire.com) - At 9:00 p.m. on July 28, Beijing time and 3:00 p.m. on July 28, Swiss time, Gotion High-Tech's GDRs were successfully listed on the SIX Swiss Exchange with the sound of six crisp bells. The Chinese Ambassador to Switzerland, Wang Shiting, Swiss SIX Group Executive Board of Directors and head of the Global Exchange Tom Zeeb, and deputy general manager of the Shenzhen Stock Exchange, Tang Rui, delivered a speech and witnessed.Mr. LI Chen, Vice President and Secretary of the Strategic Capital Section of International Business Section, and Mr. PAN Wang rang the bell on behalf of the Company at the SZSE and SZSE simultaneously.President of Engineering R&D InstituteMr. WANG Qisui, President of China Business SectionOn 7.28, the listing ceremony of the first batch of GDRs for the China-Switzerland Stock Connect was held simultaneously on the SIX Swiss Exchange, the Shenzhen Stock Exchange and the Shanghai Stock Exchange. The listed companies by issuing GDRs at the SIX Swiss Exchang include Gotion High-Tech, GEM, Shanshan and Keda Manufacturing. Among them, Gotion High-Tech is the company with the largest GDR basic issuance scale at the Swiss Stock Exchange since the implementation of the China-Euro Connect and is the only Chinese company providing new energy solutions including electric vehicle (EV) batteries and energy storage systems (ESS) batteries that have been successfully listed in Switzerland so far. Mr. CAI Yi, Senior Vice President of Gotion High-Tech and President of ITRI, and Mr. WANG Qisui, President of China Business Section, delivered speeches on behalf of the Company at the SSE and SZSE respectively.Mr. CAI Yi stated in his full English speech that the successful listing of Gotion High-Tech's GDRs is a milestone in the Company's internationalization process. We will continue to expand our production capacity around the world, continue to invest in research and development to ensure our leading position in battery technology, continue to maximize shareholder value, continue to contribute to society and support the families of our employees around the world. In his speech, Mr. WANG Qisui said that the development of Gotion High-Tech is inseparable from the support of the government, the progress of Gotion High-Tech is inseparable from the opportunities of the industry, the growth of Gotion High-Tech is inseparable from its own efforts, and the future of Gotion High-Tech is inseparable from its compliance with international rules. "The successful issuance of our GDRs represents the recognition of the industry by domestic and foreign investors, and the recognition of Gotion High-tech not only shows the determination of the Chinese government to support the development of the new energy industry but also shows the confidence of Chinese enterprises to enter the international markets. It refreshes the world's understanding of the energy revolution."According to information from the Shenzhen Stock Exchange, with the approval of the China Securities Regulatory Commission, Gotion High-Tech has been listed at the Swiss Stock Exchange on July 28. It is the project with the largest issuance scale and the smallest discount among the first batch of Swiss GDR issuance projects. The number of Gotion High-Tech's GDRs placed amounted to 22,833,400 shares, accounting for 6.4% of the total equity interest after the issuance of GDRs; the offer price was US$30.00 (the offer price represented a discount of 3.5% on the previous closing price), and the gross proceeds of the GDRs were about US$685 million. After the listing of Gotion High-Tech's GDRs, the market performance was stable. On the first day of listing, the closing price was US$30, which was the same as the offer price. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Legend Capital’s Portfolio Company Recbio Lists on HKEX Successfully

HONG KONG, Apr 7, 2022 - (ACN Newswire via SEAPRWire.com) - On 31 March 2022, Legend Capital's portfolio company Jiangsu Recbio Technology Co., Ltd. ("Recbio", stock code: 2179.HK), a leading novel vaccines company, went public on the Hong Kong Stock Exchange. The listing makes Recbio "the first HPV vaccine stock in Hong Kong" and "the first novel adjuvant vaccine stock in Hong Kong". Recbio is expected to inject new vitality into the capital market in Hong Kong.Recbio is a novel vaccine company driven by independent novel adjuvant technology. It has built a comprehensive and high-valued vaccine portfolio consisting of 12 candidates, covering cervical cancer, COVID-19, adult tuberculosis, shingles, HFMD, influenza, etc. Recbio is primarily focused on the R&D of HPV vaccine candidates. Its core product REC603, a recombinant HPV 9-valent vaccine, is currently under phase III clinical trial, and is expected to become the first approved domestic HPV 9-valent vaccine in China. In addition, Recbio has also begun to deploy in the mRNA vaccine field and is currently developing the COVID-19 mRNA vaccine.Recbio has constructed the three core technology platforms consisting of independent novel adjuvants, protein engineering and immunological evaluation. It is one of the few companies capable of independent development of novel adjuvants and the novel adjuvants it developed have been successfully applied in various innovative vaccines such as COVID-19 vaccines, HPV vaccines and shingles vaccines.Legend Capital led Recbio's Series B financing in 2020, through a coordinated investment of the comprehensive growth fund and the healthcare fund and re-upped on its Series C financing in 2021, marking Recbio another successful case towards Legend Capital's multi-fund coordinated investment. As the major institutional investor to Recbio, Legend Capital provides Recbio with multi-faceted support involving corporate governance, business strategy, technical route, R&D resources, management improvement and financial support. Dr. Liu Yong, the Founder, Chairman of the Board, and General Manager of Recbi, said, "We are much appreciated Legend Capital's long-term and firm support to Recbio. As the institutional investor with the largest shareholding in the company, Legend Capital's investment philosophy of 'Business First, People Crucial' is highly compatible with our corporate culture. Legend Capital has always supported our management team in major decision-making and continued to assist in the development, becoming one of the most trusted and respected investors of Recbio. The listing is just a new chapter of Recbio, and the management team hopes to work closely with all the investors represented by Legend Capital to write a new legend!"Hank Zhou, the Co-Chief Investment Officer of Legend Capital, said: "Congratulations to Recbio and its team led by founder Dr. Liu Yong. Liu has been engaged in vaccine research and development for over two decades, with high academic status and extensive experience in the industry. Liu's team has been deeply involved in the field of vaccine research and development for many years. Its vaccine portfolio strategically aimed at major disease and the team is actively deploying large-scale production. We admire Liu's great enthusiasm for the vaccine industry and his strong sense of responsibility and commitment. Recbio is now the leading vaccine company in China. After the successful listing, we believe that Recbio will continue to make breakthroughs in its core field of new adjuvant and vaccines to benefit more patients."Frank Hong, the Managing Director of Legend Capital, said: "After the outbreak of the pandemic, the vaccine industry has stepped into a high-speed development stage after years of accumulation on technology and talent pool. Recbio is one of the few vaccine companies with high-quality technology platforms, which can continuously produce high-quality vaccine products to meet unmet clinical needs. We are optimistic about Recbio's future of its core pipelines, including the HPV vaccine, recombinant shingles vaccine REC610 and COVID-19 vaccine. Advanced with its disruptive technology in the field of recombinant protein vaccines, Recbio is expected to be a company with strong competitiveness in the global market."Legend Capital has long paid close attention to investments in the field of life sciences. In addition to Recbio, there are other portfolio companies listed on A shares or H shares, including Pharmaron Inc. (300759.SZ; 03759.HK), KingMed Diagnostics (603882.SH), WuXi AppTec(603259.SH; 02359.HK), WuXi Biologics (02269.HK), Innovent Biologics (01801.HK), Berry Genomics (000710.SZ), Harbour BioMed (02142.HK), New Horizon Health (06606.HK), Chemclin Diagnostics (688468.SH), etc. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

EC Healthcare Included as an Eligible Stock of the Shenzhen – Hong Kong Stock Connect

HONG KONG, Mar 7, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Company has been included as an eligible stock of Shenzhen-Hong Kong Stock Connect, with effect from March 7, 2022, pursuant to the Announcement on Adjustment of the Stock List of Hong Kong Stock Connect issued by the Shenzhen Stock Exchange on March 7, 2022. Mainland investors can directly trade the Company's stock after the Company is included as an eligible stock of the Shenzhen - Hong Kong stock connect.The Company believes the inclusion of the shares of the Company in the trading mechanism of Shenzhen-Hong Kong Stock Connect demonstrates market recognition of the Company's investment value and growth prospects. The Company believes the inclusion will allow the Company to access a broader investor base in Mainland China and further expand the shareholder base of the Company, increase the trading liquidity of the shares of the Company, support the sustainable growth of the Company in the long term.The Company would like to thank the shareholders and investors of the Company for their continued support. The Company will continue to strive to develop its business to consolidate the healthcare market and create value for its shareholders.About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre SPINE Central, New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL and NEW MEDICAL CENTER, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2019 and 2020For further information, please contact: iPR Ogilvy Limited Callis Lau / Lorraine Luk / Charmaine IpTel: (852) 2136 6952 / 2169 0467 / 3920 7649Fax: (852) 3170 6606 Email: ech@iprogilvy.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option

BETHESDA, MD, Feb 21, 2022 - (ACN Newswire via SEAPRWire.com) - Alset Capital Acquisition Corp. (the "Company") announced today the closing of its initial public offering of 7,500,000 units at $10.00 per unit (the "Offering"). Each unit consists of one of the Company's shares of Class A common stock, one-half of one redeemable warrant, and one right to receive one-tenth (1/10) of one share of Class A common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. The underwriters exercised their over-allotment option in full for an additional 1,125,000 units on February 1, 2022, which closed at the time of the closing of the Offering. As a result, the aggregate gross proceeds of the Offering, including the over-allotment, are $86,250,000, prior to deducting underwriting discounts, commissions, and other Offering expenses.The units have been listed on the Nasdaq Global Market ("Nasdaq") and began trading on February 1, 2022, under the ticker symbol "ACAXU". Once the securities comprising the units begin separate trading, the shares of Class A common stock, warrants and rights are expected to be listed on Nasdaq under the symbols "ACAX," "ACAXW" and "ACAXR," respectively.The Company is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on identifying businesses in the real estate industry, including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, and adjacent businesses and technologies targeting the real estate space, which may be referred to as "Proptech" businesses.The Securities and Exchange Commission ("SEC") declared effective a registration statement on Form S-1 relating to these securities on January 31, 2022. A final prospectus relating to this Offering has been filed with the SEC. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.Forward-Looking StatementsThis press release contains statements that constitute "forward-looking statements," including with respect to the Company's initial public offering and the anticipated use of the net proceeds thereof. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and final prospectus for the Offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.ContactAlset Capital Acquisition Corp.4800 Montgomery Lane, Suite 210Bethesda, MD 20814Email: contact@alsetcapitalacquisition.comContact Number: 301-971-3955 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

乌泰·西那瓦博士/将军表示有意签署亿万富翁协议

DUBAI, Feb 11, 2022 - (亚太商讯 via SEAPRWire.com) - 乌泰·西那瓦博士/将军已接受任命，担任Capital Trust Group Limited (CTG)的荣誉顾问，这一举动必定会让全世界的金融业观察家感到兴奋。这一协议签署后，乌泰博士/将军，泰国前国防部前副常务秘书及泰国前内政部长顾问，将允许CTG在比特币基金及蓝筹股交易挑战活动（Bitcoin Fund and Bluechip Stock Trading Challenges）“业绩证明”中使用其签名。此类挑战活动面向全球18亿千禧一代，尤其关注4亿中国学生，也意味着CTG向前迈出了一大步。 就乌泰博士/将军本人而言，他会将业绩证书的发放量严格限制在1亿份以内，每份证书收取5美元的酬劳，每年报酬总额最高为5亿美元，为期4年。由乌泰博士/将军签署并批准的业绩证书将授予所有参与由Fortius Capital Foundation组织并由加密货币推广者推广的交易挑战活动且挑战活动的交易账户有所赢利的报名交易者。交易挑战活动共有30,000次，每次均由持牌的加密货币推广者推出。（签约参与Dubai Crypto Unicorn Accelerator Project项目的企业家将利用获取的报名费和交易复制费推出自己的推出自己的比特币基金及蓝筹股交易挑战活动（Bitcoin Funds and Bluechip Stock Trading Challenges））。除每次交易挑战中业绩位列前三者外，每次在线发行还将收取39美元。这是对最优秀交易者当之无愧的表彰，也是对所有交易者的鼓励。除了为比特币基金及蓝筹股交易挑战活动（Bitcoin Fund and Bluechip Stock Trading Challenges）业绩证书提供支持外，乌泰博士/将军的数字签名还将出现在“培训证书”上，该证书是一项零学费在线课程的一部分，人人均可获得。该课程名为“如何像亿万富翁一样打造投资组合”，会一步步向学生教授世界知名金融家所青睐的一些策略。这些金融家包括Chris Horn、Jim Simons、Ken Griffin、Steven Cohen，和Chase Coleman，他们所管理资产的总额超过了5,000亿美元。 联合国和平大使、CTG顾问Byung Jun Chun表示，这一活动将改变许多人的生活。用他自己的话说：“中国目前有4亿学生，他们当中大多数人没有在美国主要证券交易所进行蓝筹股交易的现场经验，所以我们很高兴能与推广人合作，通过临时账户发起在线比特币ETF x 蓝筹股交易挑战活动（Bitcoin ETF x Blue-Chip Stocks Trading Challenge）。同时，我们将提供如何像乔治·索罗斯、淡马锡控股公司、友邦保险集团或耶鲁大学那样打造投资组合的培训。这可能有助于永远改变学生的思维方式。”对乌泰博士/将军而言，他非常适合这类活动，因为他一直支持向年轻人提供金融基础能力培训。他曾谈及向更多年轻人传授金融知识从而减少全球贫困的问题。乌泰将军认为，从长远来看，这样的项目可以提高泰国经济，同时改善产品分配并吸引新的投资，因而提高国内的生活水平。Fortius Capital Foundation董事长、常驻迪拜的项目许可证持有人José Rivera Olalquiaga先生在谈到这种工作关系时说：“乌泰·西那瓦将军为全面推广我们的Dubai Crypto Unicorn Accelerator Project贡献了他的声誉，我们感到非常荣幸。这个项目不仅有可能帮助乌泰将军成为西那瓦家族第二个亿万富翁，还有助于泰国建立一个泰国本土中小企业产品（占泰国GDP的40%）的可持续分销渠道。”想了解更多如何打造投资组合的免费课程的详情，请立即访问：www.fortiuscapitalfoundation.com/freecourse。https://fortiuscapital.medium.com/general-dr-uthai-shinawatra-signals-intent-to-sign-2-billion-deal-90658e224b61联系方式:Karen Farias电话: +971503120199电子邮件: office@fortiuscapitalfoundation.com资料来源: Fortius Capital Foundation Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

Read More
Posted on

General Dr. Uthai Shinawatra Signals Intent to Sign Billionaire Deal

DUBAI, Feb 11, 2022 - (ACN Newswire via SEAPRWire.com) - In a move that is sure to excite finance-sector watchers the world over, General Dr. Uthai Shinawatra has taken an appointment to serve as the honorable advisor for Capital Trust Group Limited (CTG). General Dr. Uthai, the Former Deputy Permanent Secretary of Defense and Former Advisor to the Minister of the Interior of Thailand will thus grant CTG use of his signature on a "Certificate of Performance" for the Bitcoin Fund and Bluechip Stock Trading Challenges. These challenges, directed at 1.8 billion millennials around the world, and focusing especially on 400 million Chinese students, represent a major step forward for CTG.(Bottom row, left to right) Mr. Preecha Or-prasert, Ms. Threephatcha Buldamrongzin, Gen Dr. Uthai Shinawatra, Lt. Gen. Chumporn VichienFor his part, General Dr. Uthai will strictly limit the issuance number of the Certificates of Performance to 100 million, receiving compensation of $5 for each certificate with a maximum compensation of $500 million total per year over a 4-year period.The Certificate of Performance signed-and-approved by General Dr. Uthai will be awarded to all Trader Applicants who participate in each trading challenge organized by Fortius Capital Foundation and promoted by Crypto Promoters whose trading accounts from each trading challenge have been profitable.Each of 30,000 trading challenges will be promoted by Licensed Crypto Promoters (entrepreneurs who sign up for the Dubai Crypto Unicorn Accelerator Project to launch their own Bitcoin Funds and Bluechip Stock Trading Challenges earned from application fee and trade copying fee). There will also be a $39 fee per online issuance, except for the top three performers at each trading challenge. This is, appropriately, a way to recognize the most outstanding traders, while also including and encouraging all traders.In addition to supporting the Certificates of Performance for the Bitcoin Fund and Bluechip Stock Trading Challenges, General Dr. Uthai's digital signature will also appear on a "Certificate of Training" issued as part of a universally accessible, zero-tuition online course. The course, "How to Build an Investment Portfolio like Billionaires," will walk students through some of the strategies favored by world-renowned financiers such as Chris Horn, Jim Simons, Ken Griffin, Steven Cohen, and Chase Coleman, experts whose assets under management total more than $500 billion.Byung Jun Chun, UN Peace Ambassador, and Advisor to CTG have explained that this initiative will be a life-changer for many. In his own words: "Today, most of the 400 million Chinese students don't have live experience trading bluechip stocks on major US stock exchanges, so we are delighted to partner with promoters through our online Bitcoin ETF x Blue-Chip Stocks Trading Challenge via live accounts. At the same time, we will be providing education on how to build investment portfolios like George Soros, Temasek Holding, AIA Group, or Yale University. This can potentially help change the students' mindsets forever."For General Dr. Uthai, these initiatives seem appropriate, given his ongoing support of financial literacy education for the youth. He has spoken in the past about reducing global poverty by teaching more young people about finance. Long-term, General Dr. Uthai believes, programs such as this can enhance the Thai economy, increasing the standard of living within the country by improving product distribution and attracting new investments.Mr. Jose Rivera Olalquiaga, Chairman of Fortius Capital Foundation, the Dubai-based Project license holder, has said of the working relationship, "We are proud to have General Uthai Shinawatra contribute his reputation to fully promote our Dubai Crypto Unicorn Accelerator Project. This project is not only potentially helping General Uthai to become the second billionaire from the Shinawatra family, but also helping Thailand to have a sustainable distribution channel of local Thai SME products representing more than 40% of Thailand's GDP."To learn more about the free portfolio-building course, visit: www.fortiuscapitalfoundation.com/freecourse today.https://fortiuscapital.medium.com/general-dr-uthai-shinawatra-signals-intent-to-sign-2-billion-deal-90658e224b61Contact Info:Name: Karen FariasPhone number: +971503120199Email: office@fortiuscapitalfoundation.comSOURCE: Fortius Capital Foundation Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Society Pass (SoPa) Announces Pricing of US$10 Million Underwritten Public Offering

SINGAPORE, Feb 9, 2022 - (ACN Newswire via SEAPRWire.com) - Society Pass Incorporated (Nasdaq: SOPA) ("SoPa" or the "Company"), a leading Southeast Asian data-driven loyalty platform, today announced the pricing of its underwritten public offering of 3,030,300 shares of common stock and accompanying warrants to purchase up to 3,030,300 shares of common stock. Each share of common stock is being sold together with one warrant at a combined purchase price of US$3.30. The warrants will be immediately exercisable at a price of US$3.30 per share and will expire five years from the date of issuance. The shares of common stock and accompanying warrants can only be purchased together in the offering, but will be issued separately and will be immediately separable upon issuance. The warrants will not be listed on any exchange. Gross proceeds, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately US$10 million.The Company has granted the underwriters a 45-day option to purchase up to 454,545 additional shares of common stock and/or additional warrants to purchase up to an additional 454,545 shares of common stock at the public offering price to cover over-allotments, if any. The offering is expected to close on February 11, 2022, subject to customary closing conditions.Maxim Group LLC is acting as sole book-running manager for the offering.A registration statement relating to the Shares was declared effective by the SEC on February 8, 2022. The offering is being made only by means of a prospectus, copies of which may be obtained by contacting Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, New York 10022. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.About Society PassSoPa's customer loyalty and analytics platform has onboarded hundreds of thousands of registered consumers. SoPa provides merchants with SoPa.asia - an online commerce platform for users, alongside with #HOTTAB Biz - a convenient order management app for business partners on SoPa.asia, and #HOTTAB POS - a specialized POS technology solution, a comprehensive system for payment, loyal customer management, user's profile analytics, and convenient financial support packages for small and medium-sized enterprises. All tools offered above will allow businesses to attract and retain customers through personalized interaction based on analytics with a high profit margin. SoPa also operates www.leflair.com, Vietnam's leading lifestyle e-commerce platform. For more information, please check out: http://thesocietypass.com/Forward-Looking StatementsThe information contained herein may contain "forward-looking statements." Forward-looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of the Company concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward-looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.Contacts:PRecious Communicationssopa@preciouscomms.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Shareschart Launches Its Online Proprietary Stock Analysis Software

Kuala Lumpur, Malaysia - Recently, Shareschart team has proudly announced the launch of its automatic technical and fundamental analysis tool. It is one kind of online proprietary stock analysis software for day trading, swing trading, long term, and value investing. It attempts to assist users in recognizing and exploiting trends more quickly than the average trader and value investor, as well as tracking price movements and indicators. Shareschart is a one-of-a-kind new offering in the field of technical and fundamental analysis, with a slew of automated tools and AI-assisted technical expertise that will impress even the most seasoned traders and investors. Shareschart's program is completely free for now, and professional traders or investors who just want to go in, follow their stocks, and get back to work will appreciate Shareschart's emphasis on customisation. Their team consists of seasoned coders, traders, or (in many cases) both. Thanks to their enormous personnel and cutting-edge computer systems, they are capable of providing clients with the best possible service. The majority of experienced traders and investors utilize technical analysis to determine if a stock will rise or fall in value. Technical analysis is a sort of financial analysis that employs mathematical formulas and charting to identify patterns in the movement of a stock price or the overall market. Hand-drawing trendlines and resistance points on a candlestick or bar chart are common in technical analysis, and these trendlines are frequently incorrect and must be re-drawn. Shareschart is an automated technical analysis application that tries to eliminate the manual component of traditional technical analysis in order to get findings that are more accurate. For a more personalized technical analysis experience, Shareschart focuses primarily on customisation tools and indicators, as well as allowing users to create their own indicators/trendlines and watchlists. Trendline spotting is done automatically. Algorithms are used by Shareschart to place and calculate trendlines automatically. Users should expect Shareschart's lines to be more accurate than those placed manually because Shareschart's program uses data to create trendlines instead of the old practice of "eyeballing" where the line looks about correct. Shareschart can also be tailored to the user's preferred line drawing style. Fibonacci retracements are calculated automatically. No more guessing where their peaks and troughs are located manually, and no more wasting time calculating retracement levels. Shareschart eliminates a lot of the guesswork from technical analysis, resulting in more precise findings with their one of a kind scanner. Candlestick pattern detection is automated. Over 40 different types of candlesticks can be detected and highlighted by Shareschart's algorithms, which present them with easily identifiable designated parts. Shareschart offers technical and fundamental data for all major stock markets, including the United States, Hong Kong, China, Singapore, and Malaysia, as well as cryptocurrency. SharesChart is here to assist users with fundamental analysis and charts, regardless of their skill level. When users register a free account, you'll have access to SharesChart's charting capabilities, including the ability to construct technical and fundamental scanner and market indicators. All in all, SharesChart is a great tool for researching, charting, and filtering their favorite stocks, whether the user is an avid trader or just inquisitive about what's going on in the market. The Shareschart team is also encouraged to keep developing new tools and features because the software's performance is always improving, as evidenced by its website. For more information, please visit: www.shareschart.com  Social Links Facebook: facebook.com/shareschart Instagram: Instagram.com/shareschart Youtube: https://www.youtube.com/channel/UCPAOKgbX_Ky0b-kVTtJHUJQ Media Contact Brand: Shareschart Contact: Kimmy Lim Website: http://shareschart.com/ Email: admin@shareschart.com SOURCE: Shareschart

Read More
Posted on

KGiSL bags Broker Back Office project for Stock Exchange of Thailand

Coimbatore, India & Bangkok, Aug 19, 2021 - (ACN Newswire via SEAPRWire.com) - KGiSL, a global IT products, services and solutions provider, has announced a landmark contract win from the Stock Exchange of Thailand (SET), one of the largest stock exchanges in ASEAN, to provide a Broker Back Office platform for Thailand's brokers. KGiSL's offering, which will be hosted by SET and made available to all capital market brokers, will be based on its flagship Dolphin platform, an end-to-end back-office system that eases business operations with seamless and controlled automation. The implementation is expected to be completed within 16 months.Dolphin, the leading back office platform in India, caters to 60% of its institutional brokers, supporting back office clearing and settlement operations. Dolphin is set to become the one-stop solution for brokers in Thailand, with its ability to handle multiple asset classes including equities, bonds and offshore trading for both retail and institutional brokers. The next-generation technology platform has been tested for handling 5 million trades/day and has the potential capability to scale vertically and horizontally, supporting increases in business volumes. Dolphin was chosen over other leading systems because it was a better fit for requirements and for the robustness, scalability and automation capabilities it offers. Dr Pakorn Peetathawatchai, President, The Stock Exchange of Thailand said, "This is one of our most ambitious and challenging projects to establish a common, streamlined infrastructure that will open up new possibilities for Thai brokers to revolutionize back office business models. We strongly believe that continued support from participating brokers in providing valuable insights along with KGiSL's delivery capabilities will be key ingredients in contributing to the project's success."On the association with SET, Prassadh Shanmugam, Director & Chief Executive Officer KGiSL said, "This is a huge win for KGiSL. Dolphin has been the undisputed market leader in India so far, but we have had limited successes in other markets. This order opens up the entire ASEAN & APAC market to create similar success stories like how we have done in India. KGiSL is poised to invest more in Dolphin's capabilities by adding Artificial Intelligence (AI), Machine Learning (ML), Business Intelligence (BI) and Analytics. I would also like to thank Dr Pakorn Peetathawatchai, President of The Stock Exchange of Thailand and the entire management of SET for placing their trust in KGiSL and Dolphin."About The Stock Exchange of Thailand (SET)SET is the most liquid stock market in ASEAN with end-to-end services to empower a seamless journey for all investors, securities brokerage companies and market participants. SET has transformed toward a partnership platform by harnessing world-class technology and digital innovation to enable all parties to benefit from the Thai capital market in line with the vision 'To Make the Capital Market Work for Everyone'. A number of open architecture and interoperable platforms have been developed with the aim of building an ecosystem crucial for fundraising, wealth creation, and the country's development, widening business opportunities for operators in the securities industry while offering investors convenient access to investment data, products and services. For more information, please visit www.set.or.th.About KG Information Systems Private Ltd (KGiSL)KGISL is a global IT services, consulting and business solutions organization that has been partnering with some of the largest organisations in their transformation journeys for over 25 years. We harness the power of intelligent automation, hyper-automation, cloud, analytics and emerging technologies to power our clients to the digital world. KGiSL has offices in India, US, Malaysia, Singapore, Australia and Thailand. For more information, please visit www.kgisl.com.KGiSL is part of the $750 million business conglomerate KG Group with interest in Textiles, Engineering, Healthcare, Education, Real Estate, Entertainment, Software and Business Support Services. The Group employs over 25000 people and is known for its philanthropic services to the community for over 8 decades. Learn more at www.kgworldwide.com.For further information, please contact:KGiSL: Sampathkumar S | sampathkumar.s@kgisl.com | +66 2286 3174Adfactors PR: Bhargav TS | bhargav.ts@adfactorspr.com | +91 9884883350Adfactors PR: Namrata Sharma | namrata.sharma@adfactorspr.com | +65 8138 3034 Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

KGiSL wins Broker Back Office project for Stock Exchange of Thailand

Coimbatore, India & Bangkok, Aug 19, 2021 - (ACN Newswire via SEAPRWire.com) - KGiSL, a global IT products, services and solutions provider, has announced the landmark win of a contract from the Stock Exchange of Thailand (SET), one of the largest stock exchanges in ASEAN, to provide a Broker Back Office platform for Thailand's brokers. KGiSL's offering, which will be hosted by SET and made available to all capital market brokers, will be based on its flagship Dolphin platform, an end-to-end back-office system that eases business operations with seamless and controlled automation. The implementation is expected to be completed within 16 months.Dolphin, the leading back-office platform in India, caters to 60% of institutional brokers, supporting back-office clearing and settlement operations. Dolphin is set to become the one-stop solution for brokers in Thailand with its ability to handle multiple asset classes including equities, bonds and offshore trading for both retail and institutional brokers. The next-generation technology platform has been tested for handling 5 million trades/day and has the potential capability to scale vertically and horizontally, supporting increases in business volumes. Dolphin was chosen over other leading systems because it was a better fit for requirements and for the robustness, scalability and automation capabilities it offers. Dr Pakorn Peetathawatchai, President, The Stock Exchange of Thailand said, "This is one of our most ambitious and challenging projects to establish a common, streamlined infrastructure that will open up new possibilities for Thai brokers to revolutionize back office business models. We strongly believe that continued support from participating brokers in providing valuable insights along with KGiSL's delivery capabilities will be key ingredients in contributing to the project's success."On the association with SET, Prassadh Shanmugam, Director & Chief Executive Officer KGiSL said, "This is a huge win for KGiSL. Dolphin has been the undisputed market leader in India so far, but we have had limited successes in other markets. This order opens up the entire ASEAN & APAC market to create similar success stories like how we have done in India. KGiSL is poised to invest more in Dolphin's capabilities by adding Artificial Intelligence (AI), Machine Learning (ML), Business Intelligence (BI) and Analytics. I would also like to thank Dr Pakorn Peetathawatchai, President of The Stock Exchange of Thailand and the entire management of SET for placing their trust in KGiSL and Dolphin."About The Stock Exchange of Thailand (SET)SET is the most liquid stock market in ASEAN with end-to-end services to empower a seamless journey for all investors, securities brokerage companies and market participants. SET has transformed toward a partnership platform by harnessing world-class technology and digital innovation to enable all parties to benefit from the Thai capital market in line with the vision 'To Make the Capital Market Work for Everyone'. A number of open architecture and interoperable platforms have been developed with the aim of building an ecosystem crucial for fundraising, wealth creation, and the country's development, widening business opportunities for operators in the securities industry while offering investors convenient access to investment data, products and services. For more information, please visit www.set.or.th.About KG Information Systems Private Ltd (KGiSL)KGISL is a global IT services, consulting and business solutions organization that has been partnering with some of the largest organisations in their transformation journeys for over 25 years. We harness the power of intelligent automation, hyper-automation, cloud, analytics and emerging technologies to power our clients to the digital world. KGiSL has offices in India, US, Malaysia, Singapore, Australia and Thailand. For more information, please visit www.kgisl.com.KGiSL is part of the $750 million business conglomerate KG Group with interest in Textiles, Engineering, Healthcare, Education, Real Estate, Entertainment, Software and Business Support Services. The Group employs over 25000 people and is known for its philanthropic services to the community for over 8 decades. Learn more at www.kgworldwide.com.For further information, please contact:KGiSL: Sampathkumar S | sampathkumar.s@kgisl.com | +66 2286 3174Adfactors PR: Bhargav TS | bhargav.ts@adfactorspr.com | +91 9884883350Adfactors PR: Namrata Sharma | namrata.sharma@adfactorspr.com | +65 8138 3034 Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

KGiSL wins Common infrastructure for Brokers Back Office Project from Stock Exchange of Thailand

India / Malaysia, Aug 17, 2021 - (ACN Newswire via SEAPRWire.com) - KGiSL, a global IT Products, Solutions, and Services provider, today announced the landmark contract that was won by KGiSL against significant competition from one of the largest stock exchanges in the ASEAN, The Stock Exchange of Thailand (SET). KGiSL will rollout Dolphin - a state of the art, cutting-edge technology back-office (BO) platform for brokers in Thailand. The platform will be hosted by SET and will be made available to brokers. The implementation is expected to be completed in the next 16 months.KGiSL's flagship product for Capital Markets - Dolphin, caters to 60% of the leading institutional brokers in India by supporting their back-office clearing and settlement operations. The new platform is set to become the one-stop-shop solution to the brokers of Thailand with its ability to handle multiple asset classes including Equities, Bonds, and Offshore Trading, for both retail and institutional brokers. The next generation technology platform has been tested for handling 5 million trades/ day and has the potential capability to scale vertically and horizontally, to support any increase in business volumes. Dolphin was chosen over the other leading global platforms, because it had a better fit to the requirements and also for the robustness, scalability, and automation capabilities, it offers. Dr. Pakorn Peetathawatchai, President, The Stock Exchange of Thailand said, "This is one of our most ambitious and challenging projects to establish a common, streamlined infrastructure that will open up new possibilities for Thai brokers to revolutionize their back office business models. We strongly believe that continued support from participating brokers in providing valuable insights, along with KGiSL's delivery capability are key ingredients to contribute the project's success."On the association with SET, Prassadh Shanmugam, Director & Chief Executive Officer KGiSL said, "This is a huge win for KGiSL. Dolphin has been the undisputed market leader in India so far, but we have had limited successes in other markets. This order opens up the entire ASEAN & APAC market to create similar success stories like how we have done in India. KGiSL is poised to invest more in Dolphin's capabilities by adding Artificial Intelligence (AI), Machine Learning (ML), Business Intelligence (BI) and Analytics. I would also like to take this opportunity to thank Dr. Pakorn Peetathawatchai, President of The Stock Exchange of Thailand and the rest of the management in placing their trust in KGiSL and Dolphin."About The Stock Exchange of Thailand: www.set.or.th SET is the most liquid stock market in ASEAN with end-to-end services to empower seamless journey for all investors, securities brokerage companies and market participants. SET has transformed toward partnership platform by harnessing world-class technology and digital innovation to enable all parties to benefit from the Thai capital market in line with vision "To Make the Capital Market Work for Everyone". A number of open architecture and interoperable platforms have been developed with aims at building ecosystem crucial for fundraising, wealth creation and the country's development; widening business opportunities for operators in securities industry while offering investors convenient access to investment data, products and services.About KGiSL: www.KGISL.com/gssKGiSL is a global IT Products, Solutions, and Services provider in the BFSI space. KGiSL offers Software Products, Solutions and Services, Intelligent Automation, ERP (SAP), CRM, Business Intelligence and Analytics, Quality Engineering, IT Infrastructure Management and Custom Application Development. KGiSL has offices in India, US, Malaysia, Singapore, Australia and Thailand.KGiSL is part of the $750 million business conglomerate KG Group with interest in Textiles, Engineering, Healthcare, Education, Real Estate, Entertainment, Software and Business Support Services. The Group employs over 25000 people and is known for its philanthropic services to the community for over 8 decades.For further information, please contact:KGiSL: Sampathkumar S | sampathkumar.s@KGISL.com | +91 9940069884Adfactors PR (India): Bhargav TS | bhargav.ts@adfactorspr.com | +91 9884883350Shamitha Hegde | shamitha.hegde@adfactorspr.com | +91 9003107361 Adfactors PR (Singapore): Namrata Sharma | namrata.sharma@adfactorspr.com | +65 8138 3034 Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Fujitsu Named “Noteworthy DX Company” for 2021

TOKYO, Jun 7, 2021 - (JCN Newswire via SEAPRWire.com) - Fujitsu today announced its recognition as one of Japan's digital transformation leaders with its selection as a "Noteworthy DX Company 2021" under the Digital Transformation (DX) Stock program jointly managed by Japan's Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange.The "DX Stock" program selects leading Japanese companies engaged in digital transformation (DX)(1) that fundamentally change their business models and strengthen competitiveness through the use of digital technologies. In addition to these companies, those with an exceptionally high overall rating or that have implemented outstanding initiatives are designated under the "Noteworthy DX Company" category.METI and the Tokyo Stock Exchange selected Fujitsu in recognition of its efforts to deepen existing businesses leveraging digital technology (VOICE program for digital management based on the opinions of customers and employees) and to create entirely new business models (establishment of new company, DUCNET Co., Ltd. delivering a cloud service to promote DX in manufacturing). This marks the fifth consecutive year that Fujitsu has been honored for its efforts under this program, including past years when it was selected under the categories of "Competitive IT Strategy Company"(2) and "DX Stocks 2020."Going forward, Fujitsu will continue to contribute to society as the DX partner of choice for customers, reflecting the results and know-how of in-house DX initiatives into its solutions and services, under the guidance of its Purpose: "to make the world more sustainable by building trust in society through innovation"(3).(1) Digital Transformation (DX)the use of data and advanced technologies such as AI, IoT, cloud, and 5G to transform innovative services and business processes.(2) Competitive IT Strategy Companyan initiative by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE) to select and announce, by industry category, companies listed on the TSE that are making strategic use of IT to enhance their corporate value over the medium to long term.(3) Purposea statement describing why Fujitsu exists in societyAbout FujitsuFujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 126,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$34 billion) for the fiscal year ended March 31, 2021. For more information, please see www.fujitsu.com. Copyright 2021 JCN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Easier way to get across a busy part of Tiong Bahru Road in 1967

An overhead bridge being built in January 1967 across a busy part of Tiong Bahru Road near a block of flats. Buy this photo at: bit.ly/3e2sNkG Photonico is a website offering high-quality stock photos that celebrate Asian contemporary culture and heritage. It is a platform that showcases the thousands of editorial and stock photos that our staff and contributing photographers shoot. These photos can be purchased for personal and commercial use at an affordable price. www.photonico.asia SEARCH/BUY/USE 1. SEARCH from a vast selection of curated Asian culture and heritage photos. 2. BUY photos of old and modern Singapore, travel, nature, food, daily life and more. 3. USE the photos on different platforms with our various licensing options.  SHOOT/SHARE/EARN  1. SHOOT your own photos of Singapore and Asian street scenes, nature, daily life and travel. To contribute photos, get in touch with us at team@photonico.asia 2. SHARE them with us and be part of our community of photographers at Photonico.asia 3. EARN when your photos are sold with our 50 per cent revenue share programme.

Read More
Posted on

Volcano IPO Debut Sees Jump of 100% to 70 sen on ACE Market

KUALA LUMPUR, Apr 6, 2021 - (ACN Newswire via SEAPRWire.com) - Volcano Berhad ("VOLCANO", Stock Code: 0232), a leading international manufacturer of nameplates and plastic injection moulded parts, successfully listed on the ACE Market of Bursa Malaysia Securities Berhad ("Bursa Securities") today.From left: Volcano Berhad's Executive Director/Chief Financial Officer Khoo Boo Wui, Executive Director Gan Yew Thiam, Managing Director Datuk Ch'ng Huat Seng, Executive Director Yeap Guan Seng and Executive Director Dato' Wong Tze PengChairman of Volcano, Ms. Wong Wan Chin, said: "Aside from making the Group more visible, this IPO will also help with the expansion of Volcano. In today's highly competitive business environment, this expansion will accelerate our move towards automation and streamline our manufacturing process to ensure sustainable growth. We seek to capitalise on our current regional presence, particularly in Thailand and Singapore, to tap into the immense business opportunities available from the rising growth of the electrical and electronics and automotive industries."Volcano's foreign market accounts for more than 95% of overall revenue in the financial year ended 31 December 2020. Multinational companies comprise 90% of the sales including some leading brand names such as Bernina, Hewlett Packard, Fisher & Paykel Thailand, Donaldson Thailand, Sharp Indonesia and Panasonic Thailand.Today's listing follows from the Balloting Ceremony on 26 March where Volcano recorded an overall oversubscription rate of 176.60 times from the new shares made available to the Malaysian public."While we are humbled by the reception to our IPO from the investing public, we also recognise there are challenges with the fluctuation in raw material prices, exchange rates and the ongoing COVID-19 pandemic. Nonetheless, I am confident that Volcano will thrive as we have the knowledge, we came from hard work and experience, and we have a team of loyal, talented, committed and resourceful people. They are indeed the greatest asset of the Group. Given this, we are optimistic about our growth and future moving forward," said Wong.Trading of Volcano shares on Bursa Securities on a ready basis commenced at 9:00 A.M. (Malaysian time) on 6 April 2021, under the stock name of VOLCANO and Stock Code: 0232.TA Securities Holdings Berhad is the Principal Adviser, Sole Placement Agent, Sole Underwriter and Sponsor for the IPO exercise.For more information, please contact:Hakim JuraimiTel: +60 12-318 5410Email: h.juraimi@swanconsultancy.biz Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Tiger Brokers Singapore Achieves 100% Growth in Account Openings for Three Consecutive Quarters in 2020; Continues to Focus on Untapped Gen Z Market

- Sees Singapore as a huge potential growth market for online trading especially among the younger Singaporeans who are getting more savvy with investing online. SINGAPORE, Apr 6, 2021 - (ACN Newswire) - Tiger Brokers Singapore, the Xiaomi-backed online trading platform, today revealed continued exponential growth and momentum among its user base in Singapore. The online and mobile-focused brokerage saw 100% growth in customer accounts for three consecutive quarters in 2020. Wu Tianhua, Chief Executive Officer of UP Fintech Holding Limited shared, "The total addressable market in Singapore is huge. The country has one of the highest rates of digitalisation in the world, and a nation-wide preference for digital banking which is supported by high tech infrastructure and key fintech initiatives led by the government, making it a very attractive and relevant market for Tiger Broker's services. This is a market that has huge potential for us, and we are working hard for incremental market growth, especially focused on younger Singaporeans who are getting more savvy with their investment needs." Eng Thiam Choon, Chief Executive Officer of Tiger Brokers Singapore, also shared, "Compared to a decade ago, trading seems to be out of reach to many. However today, we are seeing an increasing number of individuals, as young as Generation Z, beginning to explore online investing as a viable financial lifestyle choice. People are more aware of the trends and developments in global economies and changes in business landscapes today. "Tiger Brokers Singapore saw an overall shift in user digital experience driven by the pandemic and recognised the need to keep pace with its investors' demands by differentiating and expanding its services. In 2020, the platform has onboarded two exchange platforms - Singapore Exchange and Australian Securities Exchange, bringing the total number of exchanges available to Singapore investors to six across five countries. This access, especially to US markets, has been a huge value-add to its investors." It has also focused on creating convenience for its users; working with bank partners to help create a seamless payment system; working with technology partners such as Iress, one of the largest and most active online trading communities; TradingView, strengthening Tiger Brokers' community engagement; and lastly, the launch of Tiger Brokers latest Fund Mall product that allows everyday-investors access to popular public funds. Tiger Brokers recently partnered with OTC Markets Group Inc. (OTCQX: OTCM) to provide customers with detailed insights and make more informed trading decisions on the OTC markets. "At Tiger Brokers, our objective is to provide an array of financial and educational tools to support the new generation of investors in their investment journey. Our fantastic Q4 result would not be made possible without the support and faith of our Singapore and regional investors. As we remind investors to diversify their investment, we hope to continue bringing value-added investment opportunities to our current investors, while attracting the new ones," shared Thiam Choon. Tiger Brokers - Growing strong and steady Tiger Brokers Singapore's parent company, UP Fintech Holding Limited (NASDAQ: TIGR) or Tiger Brokers (including all of its subsidiaries and consolidated entities), shared their unaudited financial results for the fourth quarter and the year ended December 31, 2020 with total revenue at US$47.2 million, a 136.5% increase from the fourth quarter of 2019. The total number of customers globally with deposits increased by 128.4% year-on-year to 258,700 in 2020. The global platform also added 44,000 funded accounts in the fourth quarter, 3.9 times the number of new funded accounts in the same quarter of last year; the total number of funded accounts doubled in 2020 to reach 258,700. Tiger Brokers' account balance increased by US$5.0 billion in the fourth quarter and reached US$16.0 billion, an increase of 215.9% since the end of 2019. Tiger Brokers continues to serve investors worldwide, offering access to fast trade execution and competitive transaction fees. It will continue to offer complimentary real-time stock quotes with no hidden costs, multilingual customer service during trading hours and 24/7 finance news updates. Tiger Brokers hopes to add more trading options on top of the current investment options such as Equities, ETFs, Futures, Stock Options, Warrants, Callable Bull/Bear Contracts (CBBCs), and Fund Mall. They look to add new exchange platforms to their existing six - the New York Stock Exchange (NYSE), NASDAQ, Shanghai/Shenzhen-Hong Kong Stock Connect, the Hong Kong Stock Exchange (HKEX), the Singapore Exchange (SGX) and the Australian Securities Exchange (ASX). About Tiger Brokers (Singapore) Pte Ltd. Tiger Brokers (Singapore) Pte Ltd is a brokerage firm operating with a CMS Licence from the MAS. Its Tiger Trade platform offers complimentary real-time stock quotes, dedicated multilingual customer service during trading hours and 24/7 finance news updates. The company launched the mobile version of Tiger Trade in February 2020 - accessible on Google Play Store and the Apple App Store - offering a mobile-savvy generation of retail investors similar trading opportunities as online users, such as Equities, Exchange-Traded Funds (ETFs), Futures, Stock Options, Warrants, Callable Bull/Bear Contracts (CBBCs), and Fund Mall on their mobile phones. Tiger Trade allows users to invest across multiple asset classes on the US, China, Hong Kong, Singapore and Australian stock markets such as the New York Stock Exchange (NYSE), NASDAQ, Shanghai/Shenzhen-Hong Kong Stock Connect, the Hong Kong Stock Exchange (HKEX), the Singapore Exchange (SGX) and the Australian Securities Exchange (ASX). Tiger Brokers (Singapore) is the Singapore entity of UP Fintech Holding Limited, known as Tiger Brokers in Asia, a leading online brokerage firm focusing on global investors. Founded in 2014, Tiger Brokers became #1 in the U.S. equity trading by volume among trading platforms catered to Global Chinese investors in less than two years. Tiger Brokers was awarded 2017 Fintech 250 by CB Insights and shortlisted for China Leading Fintech 50 for two years in a row by KPMG China. The company was listed on NASDAQ as TIGR in 2019 and has offices in China, United States, Australia, New Zealand and Singapore. Tiger Brokers has over 1 million customers worldwide, with a total trading volume exceeding USD219 billion in 2020. The company is backed by well-known investors such as Xiaomi, as well as investment guru Jim Rogers. For more information, please visit https://www.tigerbrokers.com.sg. For media enquiries, please contact:PRecious Communications for Tiger Brokers (Singapore)Email: Tiger@preciouscomms.com or media@tigerbrokers.com.sg This article has not been reviewed by the Monetary Authority of Singapore. Any views shared with Prospective Clients ("Prospects") are suggestive in nature and on a sample basis only. This may also be predicated on assumptions that are made by Tiger Brokers (Singapore) Pte Ltd about the Prospects' investment objectives and risk profile. Our suggestive and sample views extended to Prospects are not to be considered as recommendations made by the Company. Suggestions provided are also based on information that may be shared by the Prospects, the accuracy and comprehensiveness of which Tiger Brokers in not in a position to verify. Tiger Brokers (Singapore) Pte Ltd (herein "Tiger Brokers") may, to the extent permitted by law, participate or invest in other transactions with the issuer of the products referred to herein, perform services or solicit business from such issuers, and/or have a position or effect transactions in the securities or options thereof. The information herein is for recipient's information only and not an offer to sell or a solicitation to buy. Any date or price information is indicative only and may be changed without prior notice. All opinions expressed and facts referred to herein are subject to change without notice. The information herein was obtained and derived from sources that we believe are reliable, but while reasonable care has been taken to ensure that stated facts are accurate and opinions are fair and reasonable, Tiger Brokers does not represent that it is accurate or complete and it should not be relied upon as such. The information expressed herein is current and does not constitute an offer, recommendation or solicitation, nor does it constitute any prediction of likely future stock performance. Investment involves risk. The price of investment instruments can and do fluctuate, and any individual instrument may experience upward or downward movements, and under certain circumstances may even become valueless. Past performance is not a guarantee of future results. In preparing this information, we did not take into account the investment objectives, financial situation or particular needs of any person or affiliated companies. Before making an investment decision, you should speak to a financial adviser to consider whether this information is appropriate to your needs, objectives and circumstances. Tiger Brokers assumes no fiduciary responsibility or liability for any consequences financial or otherwise arising from trading in securities if opinions and information in this document may be relied upon.

Read More
Posted on

Joy Spreader to be included in the Hang Seng Composite Small Cap Index and Southbound Stock Connect Trading

HONG KONG, Mar 1, 2021 - (ACN Newswire) - On February 26, Hang Seng Index Company announced that Joy Spreader (06988. HK) would be included in the Hang Seng Composite Small Cap Index, meaning that it will also be soon eligible for southbound trading under Stock Connect ("Shenzhen Connect"). As we know, Southbound Stock Connect Trading has always been an important channel for mainland investors to participate in the Hong Kong stock market. The stocks selected in Southbound Stock Connect Trading generally require to fulfill a certain scale of market value and trading volume, and, to a certain extent, represent the core assets with long-term competitiveness in the Hong Kong stock market. In recent years, capital from Mainland China has constantly affected the ecology of the Hong Kong stock market. The proportion of turnover under Southbound Stock Connect Trading to the total turnover in the Hong Kong stock market has increased year by year. In the first three quarters of 2020, the turnover under Southbound Stock Connect Trading has accounted for 21.7% of the total turnover in the Hong Kong stock market.As Southbound Stock Connect Trading has played a prominent role in the Hong Kong Stock market, every adjustment to the list of Southbound Stock Connect Trading often brings great concern to the investors in the Hong Kong stock market.The reasons are that, on the one hand, a large number of funds from Mainland China flow into the Hong Kong stock market, injecting greater liquidity into the stocks under Southbound Stock Connect Trading, and improving the active stock trading; on the other hand, being eligible for the Southbound Stock Connect Trading will greatly enhance the popularity of the Company, deepen the understanding of listed companies in the capital market, and promote a further focus on the value of the Company.Take XD Inc. and China Feihe as examples. On the following day upon being eligible stocks of Southbound Stock Connect Trading, XD Inc. and China Feihe rose by 4.85% and 6.53%, respectively. In particular, the stock price of China Feihe rose by 34.07% in the following two months. After officially becoming an eligible stock of Southbound Stock Connect Trading, Joy Spreader is expected to further expand its shareholder base, improve its equity structure, and enhance its stock liquidity as well as popularity in the capital market.Joy Spreader, successfully listed on the Hong Kong Stock Exchange on September 23, 2020, is one of the leading MarTech (Marketing Technology) companies in China, providing performance-based marketing services as well as marketing SaaS services on mobile-new-media platforms, such as WeChat and DouYin. Regarding data and algorithm as the core, the Company uses its coupling technology between consumer goods/internet products and mobile-new-media content traffic to promote online marketing for both industry clients and content publishers. Specifically, not only does the Company provide cross-platform performance-based marketing services for industry clients to promote sales, but it also provides marketing SaaS services for the numerous content publishers to help them efficiently realize content/traffic value.In recent years, with the rapid outbreak of the mobile-new-media market, Joy Spreader has experienced a growth spurt. According to the latest announcement, the Company has continued the strong growth trend in 2020, with the revenue expected to be between HK$880 million and HK$920 million, representing a year-on-year increase of over 60%; the net profit (before deducting exchange gains and losses) was approximately HK$170 million to HK$200 million, representing a year-on-year increase of approximately 123.7% to 163.2%, which was 2.2 to 2.6 times as compared with the same period in 2019.The marketing SaaS serviced is another highlight of Joy Spreader. Joy Spreader began marketing SaaS services in June 2013. So far, the Company has formed a "flywheel effect" two-engine growth model with its performance-based marketing services and marketing SaaS services.The great significance of providing marketing SaaS services to we-media publishers is that the Company may automatically obtain stable and quality content resources from mobile-new-media content platforms, enabling highly efficient monetization for content publishers while conducting real-time analysis on the marketing effect, in order to provide strong support for data accumulation and algorithm iteration. It is worth mentioning that unlike most marketing technology companies, Joy Spreader is one of the few companies with the capability of providing cross-platform services. Up to now, the Company is capable of providing services on WeChat and DouYin, and other mobile-new-media content platforms at the same time.The first-mover advantage of the Company has been remarkable, particularly in the field of short videos. As early as January 2019, the Company launched the first commercial monetization service for short video content publishers at the beginning of the commercialization of DouYin, which also provided the Company with the first-mover advantage of the leading industry. With the outbreak of short video track, Joy Spreader is expected to become the greatest bonus beneficiary of the short video track. Joy Spreader is regarded as a "well-performed player in a smooth track" and a scarce investment target of the new economy in China. We are looking forward to the performance of Joy Spreader following the Stock Connect eligibility. Copyright 2021 ACN Newswire. All rights reserved. www.acnnewswire.com

Read More
Posted on

Tauriga Sciences, Inc. Signs Major Distribution Agreement with Online Grocer and Wholesaler, Stock Up Express

Stock Up Express (www.stockupexpress.com) Receives More Than 1,000,000 Annual Online Visitors, Consisting of a Diverse Group of Customers NEW YORK, NY, Jan 26, 2021 - (ACN Newswire) - via NewMediaWire - Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it has entered into a distribution agreement (the "Agreement") with Stock Up Express, a division of a leading total services distributor that generates more than $3 Billion in annual sales. Stock Up Express is based in Connecticut and is a leading web-based grocer and wholesaler with over 1,000,000 online visitors annually. The Agreement will be effective February 1, 2021, and shall remain in effect for a period of two (2) years thereafter, with automatic renewal for additional successive one (1) year terms.Under terms of the Agreement, Stock Up Express will market and resell the Company's flagship brand, Tauri-Gum(TM), to its large and diverse customer base of wholesalers and retail customers. The revenue sharing ratio established between Tauriga and Stock Up Express has the potential to create significant opportunity for both parties to this Agreement (solid gross margins). Tauri-Gum(TM) represents the first CBD edibles product/product line to be selected as part of the Stock Up Express network.The two Companies will jointly market Tauri-Gum(TM) to Stock Up Express' customer base, with input by Tauriga on the content of such marketing information to attain consistency on message and to maximize sales. The Agreement allows for modification of product offerings, and Tauriga expects to offer additional items over the course of calendar year 2021.Tauriga's CEO, Seth M. Shaw, expressed, "This agreement is an important achievement for Tauriga. Due to the quality of our flagship Tauri-Gum(TM) product line, the strong team that we have built, and the improving macro-outlook for our industry, this Agreement became possible. Stock Up Express is an outstanding distribution partner and the Company now has access to a large, previously untapped, market segment, at margins that the Company believes is conducive to long term success. Our long-term goal is for Tauri-Gum(TM) to become a successful, widely distributed, consumer friendly CBD edibles brand. We have now taken an important step in that direction."Stock Up Express' Vice President of E-Commerce, Steven Methvin, commented, "After much consideration and the evaluation of numerous CBD products, our Company has made the decision to enter the CBD edibles space through Tauriga Sciences Inc. and its high-quality products. Stock Up Express will provide an opportunity to present the Tauri-Gum(TM) brand (and possibly other product offerings to follow) to a large and engaged base of wholesalers and retail customers. Our respective teams work well together and we are all committed to working hard and strategically to build a successful distribution partnership and business model."Tauriga Sciences, Inc. was represented by the law firm of Rimon P.C. in the preparation of the Agreement.ABOUT TAURIGA SCIENCES, INC.Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol ("CBD") and Cannabigerol ("CBG") Edibles market segment. The main product line, branded as Tauri-Gum(TM), consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum(TM) Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum(TM) Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc "Immune Booster" Flavor: Pear Bellini). The Company's commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.comComplementary to the Company's retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum(TM), for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum(TM). The Patent, filed with the U.S.P.T.O. is Titled "MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT." On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.ABOUT STOCK UP EXPRESS ONLINEConvenient Warehouse Shopping:We know you need to buy lots of goods with no time to waste. That's why we created our virtual warehouse. At StockUpExpress, we sell case-size quantities of grocery, personal care, and household items from hundreds of national and regional brands. Since we are all about convenience, items in our cases are the normal shelf-size, not the jumbo club-size packaging offered at the big box stores. Unlike other e-commerce sites, StockUpExpress has the capability to ship mass amounts of product quickly and efficiently. We cover the heavy lifting and logistics, letting your business or event run smoothly all with just the click of a button. Development for Stock Up Express began in 2014. Our parent company, iMarket Technologies, LLC, was also launched in 2014 and is led by a team of executives with deep experience in warehouse operations, consumer packaged goods merchandising, logistics, and online retailing. Please visit our Website at: https://www.stockupexpress.comDISCLAIMER -- Forward-Looking StatementsThis press release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995 which represent management's beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as "may," "will," "expects," "anticipates," believes, "hopes," "believes," or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management's present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward-looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the "Risk Factors" section of Tauriga's Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.Contact:Tauriga Sciences, Inc.4 Nancy Court, Suite 4Wappingers Falls, NY 12590Chief Executive OfficerMr. Seth M. ShawEmail: sshaw@tauriga.comCell # (917) 796 9926Company Instagram: @taurigumPersonal Instagram: @sethsms47Twitter: @SethMShawCorp. Website: www.tauriga.comE-Commerce Website: www.taurigum.com Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Read More